Skip to main content
Premium Trial:

Request an Annual Quote

Cellzome Gets UK Grant for Stem Cell Tools Project

NEW YORK (GenomeWeb News) – Cellzome today said that it will lead a project that has received a €1.1 million ($1.5 million) grant from the UK's Technology Strategy Board to develop tools that better characterize human stem cells.

Heidelberg, Germany-based Cellzome will collaborate with Pfizer's Neusentis unit, the University of Sheffield, and Plasticell on the project, which will use Cellzome's Episphere technology to identify protein "fingerprints" that predict potentially deleterious changes in stem cells. The grant covers two years of funding.

The firm announced earlier this year that it would collaborate with Neusentis on studying epigenetic mechanisms involved in stem cell differentiation.

Cellzome noted that this grant is the third it has received this year leveraging its chemoproteomics platform. The other two include its part in the Blueprint collaboration to decipher epigenomes of the hematopoietic system, under which it will receive €1.2 million, and its efforts in the Orchid project, under which it is using its platform to help identify new treatments for tuberculosis.

The Scan

Rare Genetic Disease Partnership

A public-private partnership plans to speed the development of gene therapies for rare genetic diseases, Stat News writes.

Approval Sought for Alzheimer's Drug

The Wall Street Journal reports Eli Lilly has initiated a rolling submission to the US Food and Drug Administration to seek approval for its drug to treat Alzheimer's disease.

DNA Barcoding Paper Retracted

Science reports that a 2014 DNA barcoding paper was retracted after a co-author brought up data validity concerns.

Nature Papers Present Genomic Analysis of Bronze Age Mummies, Approach to Study Host-Pathogen Interactions

In Nature this week: analysis finds Tarim mummies had local genetic origin, and more.